TPW 8.13 Charlson Comorbidity Index as a Risk Assessment Tool for Breast Cancer Patients: A DGH Experience
Clicks: 3
ID: 324026
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
0.6
/100
3 views
2 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #352 of 432 articles by views in the british journal of surgery
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 432 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Aims This study aimed to assess the effectiveness in using the Charlson Comorbidity Index (CCI) for prediction of 10-year survival rate in patients who have been operatively treated for breast cancer, and the role of CCI to manage modifiable medical conditions. Methods The prospective study cohort consisted of 58 patients who had recently undergone curative surgery for localised breast cancer at a district general hospital (DGH) between January and July 2025. Clinical data was obtained from medical records to calculate CCI before the operation. Results The cohort consisted of all females, aged 75 to 92 (mean of 82.9). 32 (55%) were found to have comorbidities, of which 10 had modifiable medical conditions. The CCI calculated ranged from 5 to 7 (mean of 6). 5 of those with modifiable comorbidities were enrolled on a separate treatment programme, all of which showed marked improvement verified by formal clinical assessment. A total of 4 (7%) minor complications were identified and managed appropriately. Conclusion CCI aided in numerically stratifying patients into risk groups. This provided an opportunity to identify and optimise management of those with modifiable conditions, which contributed to improvement in prognosis and reduced complication rates. CCI served as a vital tool in the prediction of long-term survival rates, and to adapt management schemes based on modifiable comorbidities. Including CCI in treatment planning emphasised the importance of comprehensive patient assessments in the clinical practice, and for enhancing outpatient management.
| Reference Key |
openalex_W7172483513
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Neel Murthy, Krishnamurthy Murthy |
| Journal | the british journal of surgery |
| Year | 2026 |
| DOI |
10.1093/bjs/znag087.400
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.